Tratamento inovador contra o câncer pode chegar a mais pacientes no SUS 💉🌍 episode artwork

EPISODE · May 21, 2026 · 24 MIN

Tratamento inovador contra o câncer pode chegar a mais pacientes no SUS 💉🌍

from MIT Technology Review Brasil · host TEC.INSTITUTE

Melanoma, câncer de pulmão, esôfago, mama triplo negativo e colo do útero devem ser as primeiras doenças beneficiadas com o uso de imunoterapia no SUS. A informação foi dada por Rodrigo Cruz, Diretor de Relações Institucionais da MSD, farmacêutica que assinou um termo para a transferência de tecnologia com o governo federal.Nesse episódio do podcast de Biotech and Health, Camila Pepe e Carolina Abelin conversam com o executivo sobre os detalhes do acordo, os prazos e as vantagens da imunoterapia. O diferencial desse tipo de tratamento é que, ao contrário da quimioterapia tradicional, ele é capaz de estimular o próprio sistema de defesa do organismo para combater as células cancerígenas.

Melanoma, câncer de pulmão, esôfago, mama triplo negativo e colo do útero devem ser as primeiras doenças beneficiadas com o uso de imunoterapia no SUS. A informação foi dada por Rodrigo Cruz, Diretor de Relações Institucionais da MSD, farmacêutica que assinou um termo para a transferência de tecnologia com o governo federal.Nesse episódio do podcast de Biotech and Health, Camila Pepe e Carolina Abelin conversam com o executivo sobre os detalhes do acordo, os prazos e as vantagens da imunoterapia. O diferencial desse tipo de tratamento é que, ao contrário da quimioterapia tradicional, ele é capaz de estimular o próprio sistema de defesa do organismo para combater as células cancerígenas.

NOW PLAYING

Tratamento inovador contra o câncer pode chegar a mais pacientes no SUS 💉🌍

0:00 24:31

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Flottengeflüster ALD Automotive Österreich | LeasePlan Beim Flottengeflüster powered by ALD Automotive | LeasePlan präsentieren Jörg Janik und Peter Gutenbrunner alle zwei Wochen spannende Informationen rund um das Thema nachhaltige Mobilität. Beide beschäftigen sich schon lange mit der Thematik und bringen umfangreiches Fachwissen mit. Sollten sie aber doch einmal nicht weiter wissen, werden unsere Expert*innen hinzugezogen, die ihnen gerne mit Rat und Tat zur Seite stehen. XXX Tech by SOVRYN Dr. Brian Sovryn The crossroads between technology, sensuality, and metaphysics - and the longest running anarchist podcast in the world! Brought to you by Dr. Brian Sovryn. Solving for Change MOBIA Technology Innovations Solving for Change welcomes business and technology leaders to share stories of bold business transformation within complex organizations. In an era when technology and markets are changing around businesses, the key to staying competitive is to evolve in response to those changes.  MOBIA’s Mike Reeves and Marc LeBlanc investigate business transformation, deconstructing the challenges, ambitions, and market disruptions that drive companies to embark on transformation journeys, and exploring their unique approaches to achieving meaningful outcomes.  What sparks leaders to pursue business transformation? How do they overcome the challenges along the way? What are the keys to creating enduring change?  Through in-depth conversations with business and technology leaders, Mike and Marc answer these questions and explore how businesses evolve by pulling four key transformation levers: people, process, technology, and culture. Powering the Middle TJ Wilde The podcast that celebrates the backbone of America, our middle class and small businesses. We dive into the challenges that harm consumers. Threaten businesses and undermine our economy. How do we blend timeless values and traditions with modern technology to secure a brighter future? Come explore how middle class values and small businesses can keep driving the economy, creating jobs, and offering the American dream

Frequently Asked Questions

How long is this episode of MIT Technology Review Brasil?

This episode is 24 minutes long.

When was this MIT Technology Review Brasil episode published?

This episode was published on May 21, 2026.

What is this episode about?

Melanoma, câncer de pulmão, esôfago, mama triplo negativo e colo do útero devem ser as primeiras doenças beneficiadas com o uso de imunoterapia no SUS. A informação foi dada por Rodrigo Cruz, Diretor de Relações Institucionais da MSD, farmacêutica...

Can I download this MIT Technology Review Brasil episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!